Longitudinal Changes in Insulin Sensitivity and Beta Cell Function Between Women with and Without a History of Gestational Diabetes Mellitus

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2013 Sep 14

PMID 24030069

Citations 33

Authors

Anny H Xiang

Miwa Takayanagi

Mary Helen Black

Enrique Trigo

Jean M Lawrence

Richard M Watanabe

Thomas A Buchanan

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: The aim of the study was to compare longitudinal changes in insulin sensitivity (SI) and beta cell function between women with and without a history of gestational diabetes mellitus (GDM).

Methods: The prospective follow-up cohort included 235 parous non-diabetic Mexican-American women, 93 with and 142 without a history of GDM. The participants underwent dual-energy x-ray absorptiometry, OGTTs and IVGTTs at baseline and at a median of 4.1 years follow-up. The baseline values and rates of change of metabolic measures were compared between groups.

Results: At baseline, women with prior GDM (mean age 36.3 years) had similar values of SI but higher percentages of body fat and trunk fat (p ≤ 0.02), a lower acute insulin response and poorer beta cell compensation (disposition index [DI]) (p < 0.0001) than women without GDM (mean age 37.9 years). During the follow-up, women with GDM had a faster decline in SI (p = 0.02) and DI (p = 0.02) than their counterparts without GDM, with no significant differences in changes of weight or fat (p > 0.50). Adjustment for baseline age, adiposity, calorie intake, physical activity, age at first pregnancy, additional pregnancies and changes in adiposity during follow-up increased the between-group differences in the rates of change of SI and DI (p ≤ 0.003).

Conclusions/interpretation: Mexican-American women with recent GDM had a faster deterioration in insulin sensitivity and beta cell compensation than their parous counterparts without GDM. The differences were not explained by differences in adiposity, suggesting more deleterious effects of existing fat and/or reduced beta cell robustness in women with GDM.

Citing Articles

Sleep Characteristics and Long-Term Risk of Type 2 Diabetes Among Women With Gestational Diabetes.

Yin X, Bao W, Ley S, Yang J, Cuffe S, Yu G JAMA Netw Open. 2025; 8(3):e250142.

PMID: 40042841 PMC: 11883505. DOI: 10.1001/jamanetworkopen.2025.0142.

Gestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications.

Lee J, Lee N, Moon J Endocrinol Metab (Seoul). 2025; 40(1):10-25.

PMID: 39844628 PMC: 11898322. DOI: 10.3803/EnM.2024.2264.

The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices.

Phillips N, Mareschal J, Biancolin A, Sinturel F, Umwali S, Blanc S Diabetologia. 2024; 68(2):419-432.

PMID: 39531039 PMC: 11732869. DOI: 10.1007/s00125-024-06318-x.

Inhibitory Effect of TCF7L2 on Pancreatic β-Cell Dedifferentiation via ERK/MAPK Signaling Pathway in Diabetes.

Wu H, Ma Q, Liu Y, Wu X, Wen J Clin Med Insights Endocrinol Diabetes. 2024; 17:11795514241295620.

PMID: 39473826 PMC: 11520015. DOI: 10.1177/11795514241295620.

Perspectives of stakeholders on the implementation of a dietary and exercise intervention for postpartum mothers with a history of gestational diabetes mellitus (GDM): a community-based qualitative study.

Sundarapperuma T, Hettiarachchi P, Wasalathanthri S, Wijesinghe C Sci Rep. 2024; 14(1):20780.

PMID: 39242616 PMC: 11379962. DOI: 10.1038/s41598-024-71587-w.

References

Feig D, Zinman B, Wang X, Hux J . Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ. 2008; 179(3):229-34. PMC: 2474881. DOI: 10.1503/cmaj.080012. View

Xiang A, Peters R, Kjos S, Marroquin A, Goico J, Ochoa C . Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes. 2006; 55(2):517-22. PMC: 1389697. DOI: 10.2337/diabetes.55.02.06.db05-1066. View

Boston R, Stefanovski D, Moate P, Sumner A, Watanabe R, Bergman R . MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2004; 5(6):1003-15. DOI: 10.1089/152091503322641060. View

Xiang A, Kawakubo M, Trigo E, Kjos S, Buchanan T . Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care. 2009; 33(2):396-401. PMC: 2809290. DOI: 10.2337/dc09-1493. View

Ratner R, Christophi C, Metzger B, Dabelea D, Bennett P, Pi-Sunyer X . Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008; 93(12):4774-9. PMC: 2626441. DOI: 10.1210/jc.2008-0772. View

Catalano P, Huston L, Amini S, Kalhan S . Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol. 1999; 180(4):903-16. DOI: 10.1016/s0002-9378(99)70662-9. View

Catalano P, Tyzbir E, Wolfe R, Calles J, Roman N, Amini S . Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am J Physiol. 1993; 264(1 Pt 1):E60-7. DOI: 10.1152/ajpendo.1993.264.1.E60. View

Black M, Fingerlin T, Allayee H, Zhang W, Xiang A, Trigo E . Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes. 2007; 57(4):1048-56. PMC: 4447520. DOI: 10.2337/db07-0848. View

Xiang A, Li B, Black M, Sacks D, Buchanan T, Jacobsen S . Racial and ethnic disparities in diabetes risk after gestational diabetes mellitus. Diabetologia. 2011; 54(12):3016-21. DOI: 10.1007/s00125-011-2330-2. View

10.

Buchanan T, Xiang A, Page K . Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012; 8(11):639-49. PMC: 4404707. DOI: 10.1038/nrendo.2012.96. View

11.

Homko C, Sivan E, Chen X, Reece E, Boden G . Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab. 2001; 86(2):568-73. DOI: 10.1210/jcem.86.2.7137. View

12.

Buchanan T, Xiang A . Gestational diabetes mellitus. J Clin Invest. 2005; 115(3):485-91. PMC: 1052018. DOI: 10.1172/JCI24531. View

13.

Li X, Allayee H, Xiang A, Trigo E, Hartiala J, Lawrence J . Variation in IGF2BP2 interacts with adiposity to alter insulin sensitivity in Mexican Americans. Obesity (Silver Spring). 2009; 17(4):729-36. PMC: 4357482. DOI: 10.1038/oby.2008.593. View

14.

Chen Z, Black M, Watanabe R, Trigo E, Takayanagi M, Lawrence J . Self-reported physical activity is associated with β-cell function in Mexican American adults. Diabetes Care. 2012; 36(3):638-44. PMC: 3579363. DOI: 10.2337/dc12-1485. View

15.

Retnakaran R, Qi Y, Sermer M, Connelly P, Hanley A, Zinman B . Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care. 2010; 33(8):1798-804. PMC: 2909065. DOI: 10.2337/dc10-0351. View

16.

Nothlings U, Wilkens L, Murphy S, Hankin J, Henderson B, Kolonel L . Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Cancer Causes Control. 2007; 18(2):165-75. DOI: 10.1007/s10552-006-0100-0. View

17.

Bellamy L, Casas J, Hingorani A, Williams D . Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009; 373(9677):1773-9. DOI: 10.1016/S0140-6736(09)60731-5. View

18.

Bergman R . Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989; 38(12):1512-27. DOI: 10.2337/diab.38.12.1512. View

19.

Xiang A, Peters R, Trigo E, Kjos S, Lee W, Buchanan T . Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. Diabetes. 1999; 48(4):848-54. DOI: 10.2337/diabetes.48.4.848. View

20.

Watanabe R, Allayee H, Xiang A, Trigo E, Hartiala J, Lawrence J . Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes. 2007; 56(5):1481-5. PMC: 2925638. DOI: 10.2337/db06-1682. View